Hot
Description
Breast Pathology Update 2025 – Comprehensive CME
Original Release Date: July 28, 2025
Breast Pathology Update 2025 provides a Premier, evidence-based review of benign, in situ, and malignant breast lesions in both surgical specimens and core needle biopsies. This Expert-led CME course highlights immunohistochemical and molecular advances, prognostic and predictive assays, and AI applications in breast pathology for improving patient management and outcomes.
Target Audience
Designed for practicing academic and community pathologists, as well as pathologists-in-training who aim to enhance diagnostic precision and stay updated with cutting-edge advances in breast pathology.
Learning Objectives
- Describe diagnostic criteria and clinical significance of benign, in situ, and malignant breast lesions
- Discuss differential diagnoses and limitations of immunohistochemical & molecular testing
- Apply prognostic and predictive assays to patient management in breast cancer
Course Topics & Faculty
| Topic | Faculty |
|---|---|
| Intraductal Proliferative Lesions | Ashley Cimino-Mathews, MD |
| LCIS Classification & Management | Stuart Schnitt, MD |
| Breast Core Needle Biopsies – Issues | Laura Collins, MD |
| Digital Slides: Small Glandular Proliferations | Laura Collins, MD |
| Atypical Intraductal Proliferations | Cecily Quinn, MD, FRCPath |
| Papillary Proliferations | Edi Brogi, MD, PhD |
| Fibroepithelial & Apocrine Lesions | Puay Hoon Tan, MD / Cecily Quinn, MD |
| Spindle Cell & Vascular Lesions | Gregory Bean, MD, PhD |
| Molecular Testing Applications | Ashley Cimino-Mathews, MD |
| Triple Negative Breast Cancers | Ashley Cimino-Mathews, MD / Laura Collins, MD |
| HER2 Low & ER Low Breast Cancers | Stuart Schnitt, MD |
| Pathology After Neoadjuvant Therapy | Gregory Bean, MD, PhD |
| Mucinous & Neuroendocrine Lesions | Puay Hoon Tan, MD |
| Epithelial-Myoepithelial Proliferations | Puay Hoon Tan, MD |
| Contemporary Lymph Node Evaluation | Edi Brogi, MD, PhD |
| AI Applications in Breast Pathology | Stuart Schnitt, MD |
Why Enroll?
- Comprehensive review of breast pathology from benign to malignant lesions
- Exclusive lectures by world-renowned pathology faculty
- Cutting-edge updates in IHC, molecular studies & AI integration
- Digital slide reviews to strengthen practical diagnostic skills
👉 Explore More Pathology CME Courses
FAQ
What is the release date of this program?
The original release date is July 28, 2025.
Who should take this course?
Academic and community pathologists, and trainees seeking comprehensive updates in breast pathology.
What makes this course unique?
It covers the latest IHC, molecular, and AI applications for diagnostic precision and patient management.
What formats are included?
Lectures, digital slides, and panel Q&A sessions for interactive and applied learning.
